Helen de Beer
The global chemicals industry experienced a slump following the pandemic, though PE's share of the market is holding steady.
Our upcoming special report on the secondaries market shows the future looks bright for this burgeoning asset class – though investors have a list of improvements they’d like to see.
As Asia-Pacific’s fundraising slump continues, hopes are being pinned on the southeast.
While fundraising timelines have stretched, the percentage of funds to have exceeded their target at final close is at its highest level since 2008.
Despite a recent drop in deal activity and fundraising, private equity in the Nordic region has been catching the eyes of investors due to attractive returns.
The biggest fundraiser on the 2024 PEI 300 ranking brought in nearly $124bn over the past five years.
Newcomers are flocking to the market, drawn by a growing base of targets and the promise of increased fund sizes.
Vastly expanded powers by the US health department means PE firms will need to provide greater transparency and accountability in how they run their healthcare businesses.
The alternatives giant doesn't want to enter the sub-sector if it can't be a top-three player, according to chief financial officer Rob Lewin.
Banks that are unaware of the extent of their exposure to private equity could face ‘severe, unexpected losses’, according to the UK’s central bank.